1. Pink Sheet
  2. >>Market Access
  3. >>Government Payers

340B ‘Penny Pricing’ Policy Formally Adopted By HHS; Overcharging Safe Harbors Created

 
• By Cathy Kelly

Final rule on 340B discounts also addresses how to handle pricing for new drugs.

US pennies

HHS has decided to formalize its “penny pricing” policy for prescription drugs sold at 340B discounts despite arguments from manufacturers that alternatives allowing for higher prices should be adopted.

“After consideration of the comments received, HHS is finalizing the penny pricing policy as proposed,” according to a

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Medicaid

More from Government Payers

Pink Sheet Podcast: The US and Ex-US Impact Of Most-Favored Nation Drug Pricing

 
• By Derrick Gingery, Francesca Bruce, Cathy Kelly, and Nielsen Hobbs

Pink Sheet reporter and editors discuss the potential impact of the Most-Favored Nation drug pricing proposal on Europe, the United States, as well as the pharmaceutical industry.

PCMA, CVS, Cigna File Lawsuits Over ‘Dangerous’ Arkansas PBM Law

 
• By Tim Casey

The suits are an early test of the Arkansas law banning company ownership of PBMs and pharmacies in the state, as other states consider similar legislation.

Medicare Part D LIS Access Threatened By House Budget Bill’s Medicaid Obstacles

 
• By Cathy Kelly

An unintended consequence of a provision framed as an administrative change in the bill could significantly reduce medication adherence among low-income older adults and increase mortality, a study found.